Spectra Optia Apheresis System
K-Number: K181049 · 2018-11-01
Device Summary
Frequently Asked Questions
What is the Spectra Optia Apheresis System?
Spectra Optia Apheresis System is a medical device that received FDA 510(k) clearance on 2018-11-01. The listed applicant is Terumobct, Inc.. The 510(k) number is K181049.
When did Spectra Optia Apheresis System receive FDA 510(k) clearance?
Spectra Optia Apheresis System received FDA 510(k) clearance on 2018-11-01, under 510(k) number K181049.
Who is the listed applicant for Spectra Optia Apheresis System?
The FDA 510(k) record lists Terumobct, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Spectra Optia Apheresis System?
The FDA product code for Spectra Optia Apheresis System is LKN.
Other records listing Terumobct, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LKN)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.